Powder and solvent for suspension for Intravesical use.

After reconstitution, one vial contains BCG (Bacillus Calmette-Guérin) bacteria seed RIVM derived from seed 1173-P2, 2 x 108 to 3 x 109 viable units.

Indicated for Treatment of non-invasive urothelial bladder carcinoma: 

1. curative treatment of carcinoma in situ; 
2. prophylactic treatment of recurrence of : 

• urothelial carcinoma limited to mucosa : Ta G1-G2 if multifocal and/or recurrent tumour, Ta G3, 
• urothelial carcinoma in lamina propia but not the muscular of the bladder (T1), c) carcinoma in situ.

BCG-medac Kit contains:

• BCG vial
• Closed Instillation Kit
• Catheter
• Clip and Disposal bag

Powder and solvent for intravesical solution 10mg, 20m and 40mg

Mitomycin medac is indicated as intravesical administration for relapse prevention in adult patients with superficial urinary bladder carcinoma after transurethral resection.

Mitomycin medac kit contains:

• 20mg or 40mg vial
• Closed instillation kit
• Male and female catheter
• Clip and disposal bag